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http://dx.doi.org/10.1016/j.bgm.201Abstract Retroperitoneal malignant melanomas, either primary or metastatic, are rare. We
present our clinical experience concerning one case with ileus secondary to a huge retroper-
itoneal malignant melanoma. A 77-year-old woman was admitted to the hospital due to pro-
gressive abdominal fullness and decreased appetite for 4 months. Plain films showed soft-
tissue density in the left lower quadrant of the abdomen, as well as rightward displacement
of the intestine. Laboratory data excluded any metabolic or septic causes of ileus. Abdominal
computed tomography scan identified a huge retroperitoneal tumor with invasion of the left
lower peritoneal space. The mass measured approximately 18.2  21.5 cm in the largest sec-
tion. Immunohistochemical analysis of the tumor biopsies at minilaparotomy showed positive
staining of tumor cells for S-100 protein, human melanoma black-45, and vimentin. Thus, a
diagnosis of malignant melanoma with peritoneal metastases was established. This case high-
lights the possibility of a retroperitoneal malignant melanoma exerting a mass effect on the
surrounding organs. The authors suggest that malignant melanoma should be taken into consid-
eration as a possible differential diagnosis of retroperitoneal neoplasms.
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114 C.-F. Chen et al.IntroductionMelanomas are derived from melanocytes, which origi-
nate from the neural ectoderm and migrate to the skin,
eyes, and leptomeninges in early embryonal life.1
Compared with most malignant melanoma that occurs
primarily in the skin, fewer than 10% of malignant mel-
anomas arise from noncutaneous regions, including the
choroid layer of the eyes, the leptomeninges, oral mu-
cosa, and the mucosa of the gastrointestinal, respira-
tory, and genitourinary tracts.2 Malignant melanoma
arising in the retroperitoneum is extremely rare. Here,
we report a case with ileus secondary to a huge retro-
peritoneal malignant melanoma and briefly review the
literature.Figure 1 Abdominal computed tomography scan of the pri-
mary retroperitoneal malignant melanoma. (A) A retroperito-
neal tumor with irregular margin, heterogenous density,
measured approximately 18.2  21.5 cm in the largest section.
(B) The tumor extended cross-midline of the abdomen,
partially enclosing the left common iliac artery (arrow).Case report
A 77-year-old woman visited our department of emer-
gency due to progressive abdominal fullness and
decreased appetite over the previous 4 months. In addi-
tion, she complained of nausea and vomiting in the pre-
vious 3 days. She had underlying diabetes mellitus as well
as ischemic heart disease, and lived in a nursing home.
General physical examination revealed abdominal
distension and hypoactive bowel sound, but no abdominal
tenderness. Plain films showed soft-tissue density in the
left lower quadrant of the abdomen, as well as rightward
displacement of the intestine. Laboratory data excluded
any metabolic or septic causes of ileus. Abdominal
computed tomography (CT) scan identified a huge retro-
peritoneal tumor with irregular margin, heterogenous
density, and invasion of the left lower peritoneal space
anteroinferiorly. The mass measured approximately
18.2  21.5 cm in the largest section (Fig. 1A) and was
clearly separable from the pancreas, kidney, and bilateral
adrenal glands. The tumor extended cross-midline of the
abdomen, partially enclosed the left common iliac artery
(Fig. 1B), and was inseparable from the left psoas muscle.
The patient underwent minilaparotomy thereafter. We
noted that the gross appearance of the mass was soft and
gray-white in color (Fig. 2A). The tumor had a paren-
chymal green-black necrotic area as well as a bleeding
tendency. Multiple metastatic lesions were noted over the
visceral and parietal peritoneum (Fig. 2B). We checked
the small intestine carefully during the operation and no
obvious intestinal mass lesions were identified. In
consideration of the patient’s intraoperative critical he-
modynamics and late stage of the malignancy, we per-
formed incisional biopsy instead of en bloc resection of
the tumor as well as the peritoneal lesions. The specimen
was evaluated by histologic analysis and immunohisto-
chemical staining. Microscopic study revealed abundant
tumor necrosis, high nuclear/cytoplasmic ratio, and
hypercellularity; with spindle or irregular nucleoli in
tumor cells (Fig. 3A). The cells showed positive staining
for S-100 protein (Fig. 3B), human melanoma black-45
(HMB-45; Fig. 3C) and vimentin (Fig. 3D), whereas cyto-
keratin AE1/AE3, cytokeratin 7, epithelial membrane an-
tigen, and CD34 were negative. Therefore, the diagnosisof malignant melanoma with peritoneal metastases was
established. The detailed history revealed that the pa-
tient had no previous melanoma. Subsequently, she was
referred for further dermatologic and ophthalmologic
examination, and no suspicious primary lesion was iden-
tified. Further investigations were also scheduled, but the
patient declined to receive subsequent examinations. Due
to poor nutritional status on admission, she received
postoperative nutritional support therapy prior to further
treatment of the Stage IV malignant melanoma. However,
systemic chemotherapy was postponed because the pa-
tient developed pneumonia in the postoperative course.
Consequently, she died 2 months after surgery.
Discussion
Primary retroperitoneal neoplasm includes a diverse group
of benign and malignant tumors that arise in the retro-
peritoneum. Due to the inaccessibility of the region and
because these tumors are often asymptomatic until they
have reached a substantial size, they are usually large at
presentation.3 Therefore, diagnosis and management of
Figure 2 Intraoperative findings. (A) The surface of the
tumor was gray-white in color grossly (double arrows). (B) One
of the peritoneal metastatic lesions was identified over the
mesentery (single arrow).
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their clinical features.
The most common symptoms in patients with retro-
peritoneal tumors remain nonspecific, including early
satiety, anemia, abdominal swelling, abdominal pain, and
back pain.4e6 Additionally, patients may also present with
a palpable abdominal mass. The most common histology
of primary retroperitoneal malignant tumors is lip-
osarcoma, followed by leiomyosarcoma.4 By contrast,
malignant melanoma arising in the retroperitoneum is
extremely rare.
In this case report, we present a case with ileus sec-
ondary to a huge retroperitoneal malignant melanoma. A
review of the literature was performed using PubMed with
the keywords “malignant melanoma” and “retro-
peritoneum” to search for all case reports and reviews
published between 1963 and 2013 on malignant melanoma
originating from the retroperitoneal space. Similar searches
were performed using Ovid MEDLINE. A solitary retroperi-
toneal malignant melanoma with a maximal diameter
>20 cm at diagnosis has not been previously reported in the
literature. Most cases reported so far with primary retro-
peritoneal malignant melanoma are of the adrenal medulla
origin.7,8 There are only seven cases reported to date as aprimary retroperitoneal malignant melanoma that origi-
nated from retroperitoneal tissue other than the adrenal
gland.8e13 Because of their rarity, the epidemiology and
clinical behavior of these tumors have not been well
characterized.
Regarding the possible etiology of primary retroperi-
toneal malignant melanoma, several authors have
pointed out that melanoma lesions may arise from the
adrenal glands, lumbar sympathetic chains, and auto-
nomic nerve plexuses.7,10 The findings may explain why
melanoma can arise within the retroperitoneal space.
Previous studies have reported that primary retroperi-
toneal malignant melanoma can cause a mass effect on
the surrounding organ.7,8,11,12 It is interesting to note
that the findings in the current case, like a solitary bulky
tumor with a mass effect, are coincident with previous
case reports of primary retroperitoneal melanoma. Most
retroperitoneal metastatic melanomas (i.e., pancreas,
kidney, lymph nodes) are usually multiple and small
lesions.14
Diagnosis of malignant melanoma in the abdomen is
generally made by radiographic studies, histopathologic
analysis, and immunohistochemical stains. Abdominal CT
scan is currently the most widely used imaging method for
tumor staging, preoperative surveillance, and a follow-up
to therapeutic response.15 However, a final diagnosis of
malignant melanoma can only be made after histopatho-
logic and immunohistochemical analysis. Cytologic features
of malignant melanoma include enlarged nuclei, prominent
nucleoli, thick and irregular nuclear membranes, abnormal
cytoplasmic melanization, and atypical mitotic figures.1
Histologically, tumor cells may be classified into four cell
types: epithelioid, spindle cell, lymphoma-like, and pleom
orphic.16
Immunohistochemical stains are now widely used for the
diagnosis of malignant melanoma. Extracutaneous mela-
nomas exhibit the same immunohistochemical and ultra-
structural features as their cutaneous counterparts.11 S-100
protein, HMB-45, melanin A, vimentin, and occasionally
antityrosinase antibodies are used as immunohistochemical
tools in the diagnosis of melanoma. S-100 protein is the
most common screening immunohistochemical stain used in
the diagnosis of melanoma and it remains the most sensi-
tive marker for melanocytic lesions (sensitivity nearly
100%).16e18 Other markers such as HMB-45, melanin A,
vimentin, and antityrosinase antibody demonstrate rela-
tively good specificity but not the same sensitivity as S-
100.18,19 The sensitivity of HMB-45 for melanoma is re-
ported to reach 93e100%, with a distribution similar to that
of melanin A,11 and the reported sensitivity of vimentin is
93%.16 Along with the wide application of immunohisto-
chemical stains, Tousignant et al20 reported that simulta-
neous positivity for S-100 protein and vimentin, confronted
with the patient’s history and with histologic features,
firmly establishes the diagnosis of malignant melanoma in
virtually all cases.
In conclusion, we report a case with ileus secondary to
a huge primary retroperitoneal malignant melanoma.
This case highlights the possibility of a retroperitoneal
malignant melanoma exerting a mass effect on the sur-
rounding organs. Finally, the authors suggest that ma-
lignant melanoma should be taken into consideration as a
Figure 3 Histologic and immunohistochemical analysis. (A) Hematoxylin and eosin stain (400) showed high nuclear/cytoplasmic
ratio and hypercellularity, with spindle or irregular nucleoli in tumor cells. (BeD) Immunohistochemical analysis demonstrated
positive staining with S-100 protein (B, 400, arrow), HMB-45 (C, 400, arrow), and vimentin (D, 400, arrow).
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